Personalizing the Use of a Intermittently Scanned Continuous Glucose Monitoring (isCGM) Device in Individuals With Type 1 Diabetes: A Cost-Effectiveness Perspective in the Netherlands (FLARE-NL 9).
Sajad EmamipourPeter R van DijkHenk J G BiloMireille A EdensOnno van der GaliënMaarten J PostmaTalitha L FeenstraJob F M van BovenPublished in: Journal of diabetes science and technology (2022)
Comparing subgroups of isCGM users allows to prioritize them based on cost-effectiveness. The most cost-effective subgroup was occupation-related indications, followed by multiple indications, high HbA1c and the frequent hypoglycemic events subgroups. However, controlled studies with larger sample size are needed to draw definitive conclusions.